Mertigo SR sustained-release tablets
Dexa Medica
Ingredients in every sustained-release tablet
Betahistine | 12 mg |
Each package contains
10 strips of 10 sustained-release tablets
Other details
Dosage form:Tablet; coated; sustained-release
Flavour | None |
W.H.O. classification
ATC Level 1 | N - Nervous system |
ATC Level 2 | N07 - Other Nervous System Drugs in ATC |
ATC Level 3 | N07C - Antivertigo Preparations |
Warnings
Pregnancy
CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.
Available in
![]() |
Indonesia |
Dosage information
18 YEARS OLD AND ABOVE
1 sustained-release tablet (12 mg of betahistine mesylate) twice daily, taken orally after each meal. Betahistine mesylate sustained-release tablet must be swallowed whole and never crushed or chewed.
Indication
To relieve vertigo, dizziness which related to vestibular disorder in blood circulation disorder or Meniere’s syndrome, Meniere’s disease, and peripheral vertigo.